Notices

Deltamethrin and Xylene will be considered for listing as reproductive/developmental toxicants by the DART IC.  Hazard identification material available for review and comment.

Intent to List: Benzophenone, coconut oil diethanolamine condensate (cocamide diethanolamine), diethanolamine and 2-methylimidazole as known to the State to cause cancer.

On  December 21, 2011, the Office of Administrative Law approved the adoption of Title 27, California Code of Regulations.

Notice of a change to a proposed No Significant Risk Level (NSRL) for chlorothalonil from 27 ug/day to 41 ug/day.

Comment Period - Notice of Modification of Proposed Regulation Title 27, California Code of Regulations, Amendment to Section 25705 - Specific Regulatory Levels Posing No Significant Risk: Chlorothalonil

Intent to list methyl isopropyl ketone by the Labor Code mechanism.

This action amends existing procedures governing service of a 60-day notice under Proposition 65 by establishing an alternative procedure for serving notices on the Attorney General via electronic mail.

Notice of intent to list kresoxim-methyl and tetraconazole as known to the State to cause cancer.

Modification of the listing of glasswool fibers (airborne particles of respirable size) to glass wool fibers (inhalable and biopersistent) based on the authoritative bodies mechanism (NTP, 2011).

Notice of Amendment - Title 27, California Code of Regulations Amendment of Section 25703(a)(6): Quantitative Risk Assessment. The amendment modifies the calculation used to convert estimates of animal cancer potency to estimates of human cancer potency, which is used to calculate no significant risk levels for carcinogens listed under Proposition 65.

OEHHA has selected the chemicals below for the CIC’s review for possible listing under Proposition 65. OEHHA is initiating the development of hazard identification materials on C.I. Disperse Yellow 3, Dibenzanthracenes and dibenz[a,c]anthracene.

On September 23, 2011, OEHHA published a notice in the California Regulatory Notice Register (Register 2011, No.

Estrogen–progestogen (combined) used as menopausal therapy, etoposide, etoposide in combination with cisplatin and bleomycin, methyl isobutyl ketone, MOPP (vincristine-prednisone-nitrogen mustard-procarbazine mixture) listed as known to cause cancer under Proposition 65.

Meeting Synopsis and Slide Presentations Carcinogen Identification Committee Meeting Held on October 12, 2011

Extension of public comment period regarding the removal of the reference to hexavalent chromium in Section 25707(b)(4) as posing no significant risk when ingested. 

Tris(1,3-dichloro-2-propyl) phosphate (TDCPP) was listed effective 10/28/2011 as known to the State to cause cancer.

Extension of comment period regarding the establishment of a specific regulatory level posing no significant risk for Imazalil.

Notice of adoption to text of regulations Title 27, California Code of Regulations amendment to section 25805 Maximum Allowable Dose Level (MADL) for Avermectin B1

Extension of public comment period on the changed notice of proposed rulemaking establishing a  No Significant Risk Level: 4-Methylimidazole (4-MEI).

Announcement of the October 12th and 13th2011 CIC meeting and hazard ID materials for fluoride and its salts, and tris(1,3-Dichloro-2-Propyl) phosphate.  Both will be considered for listing at the October 2011 meeting.